BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17405130)

  • 1. Homology modeling of the serotonin transporter: insights into the primary escitalopram-binding site.
    Jørgensen AM; Tagmose L; Jørgensen AM; Topiol S; Sabio M; Gundertofte K; Bøgesø KP; Peters GH
    ChemMedChem; 2007 Jun; 2(6):815-26. PubMed ID: 17405130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.
    Indarte M; Madura JD; Surratt CK
    Proteins; 2008 Feb; 70(3):1033-46. PubMed ID: 17847094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homology model of SERT based on the LeuT(Aa) template.
    Ravna AW; Jaronczyk M; Sylte I
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5594-7. PubMed ID: 16919451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular interactions of buspirone analogues with the serotonin transporter.
    Jarończyk M; Chilmonczyk Z; Mazurek AP; Nowak G; Ravna AW; Kristiansen K; Sylte I
    Bioorg Med Chem; 2008 Oct; 16(20):9283-94. PubMed ID: 18812261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination of Na(+) by monoamine ligands in dopamine, norepinephrine, and serotonin transporters.
    Xhaard H; Backström V; Denessiouk K; Johnson MS
    J Chem Inf Model; 2008 Jul; 48(7):1423-37. PubMed ID: 18543980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations.
    Koldsø H; Severinsen K; Tran TT; Celik L; Jensen HH; Wiborg O; Schiøtt B; Sinning S
    J Am Chem Soc; 2010 Feb; 132(4):1311-22. PubMed ID: 20055463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation.
    Celik L; Sinning S; Severinsen K; Hansen CG; Møller MS; Bols M; Wiborg O; Schiøtt B
    J Am Chem Soc; 2008 Mar; 130(12):3853-65. PubMed ID: 18314975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of the zebrafish serotonin transporter functionally links TM10 to the ligand binding site.
    Severinsen K; Sinning S; Müller HK; Wiborg O
    J Neurochem; 2008 Jun; 105(5):1794-805. PubMed ID: 18266934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nucleoside transport proteins, NupC and NupG, from Escherichia coli: specific structural motifs necessary for the binding of ligands.
    Patching SG; Baldwin SA; Baldwin AD; Young JD; Gallagher MP; Henderson PJ; Herbert RB
    Org Biomol Chem; 2005 Feb; 3(3):462-70. PubMed ID: 15678184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulations of Na+/Cl(-)-dependent neurotransmitter transporters in a membrane-aqueous system.
    Jørgensen AM; Tagmose L; Jørgensen AM; Bøgesø KP; Peters GH
    ChemMedChem; 2007 Jun; 2(6):827-40. PubMed ID: 17436258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
    Andersen J; Olsen L; Hansen KB; Taboureau O; Jørgensen FS; Jørgensen AM; Bang-Andersen B; Egebjerg J; Strømgaard K; Kristensen AS
    J Biol Chem; 2010 Jan; 285(3):2051-63. PubMed ID: 19892699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporter.
    Combs S; Kaufmann K; Field JR; Blakely RD; Meiler J
    ACS Chem Neurosci; 2011 Feb; 2(2):75-81. PubMed ID: 22778858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action.
    Kortagere S; Fontana AC; Rose DR; Mortensen OV
    Neuropharmacology; 2013 Sep; 72():282-90. PubMed ID: 23632081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of an allosteric mechanism on the serotonin transporter: a cross-species study.
    Neubauer HA; Hansen CG; Wiborg O
    Mol Pharmacol; 2006 Apr; 69(4):1242-50. PubMed ID: 16434615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structures and mechanism of the human serotonin transporter.
    Coleman JA; Green EM; Gouaux E
    Nature; 2016 Apr; 532(7599):334-9. PubMed ID: 27049939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium translocation by the iminoglycinuria associated imino transporter (SLC6A20).
    Bröer A; Balkrishna S; Kottra G; Davis S; Oakley A; Bröer S
    Mol Membr Biol; 2009 Aug; 26(5):333-46. PubMed ID: 19657969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.
    Singh SK; Yamashita A; Gouaux E
    Nature; 2007 Aug; 448(7156):952-6. PubMed ID: 17687333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative drug binding conformations of monoamine transporters.
    Ravna AW; Sylte I; Kristiansen K; Dahl SG
    Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
    Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
    J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling and mutational evidence identify the substrate binding site and functional elements in APC amino acid transporters.
    Vangelatos I; Vlachakis D; Sophianopoulou V; Diallinas G
    Mol Membr Biol; 2009 Aug; 26(5):356-70. PubMed ID: 19670073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.